where's our liver trial....?, page-5

re: where's our liver trial? could this be it?? Henrikc,

Bit intrigued myself re this program segment last night, no mention of the drug and no mention of the Company, but I suspect not Progen and therefore neither PI 88 nor PI 166. The reference to colon cancer which to my knowledge has not been presented previously by the company as one of the treatable cancers by their compounds. But what a huge endorsement for angiogenisis treatment which of course is the entire thrust of the Progen compounds and should the drug in use have been Avastin then PI-88's modes of operation are multiple compared to the single mode of operation of Avastin. Looks good for Progen, but roll on for goodness sake the licensing agreement with the major pharma. How long does it take to write a contract?